{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:16:18Z","timestamp":1767860178147,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T00:00:00Z","timestamp":1407456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1472-6963-14-337","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T01:01:21Z","timestamp":1407459681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Regional differences in performance of bone marrow transplantation, care-resource use and outcome for adult T-cell leukaemia in Japan"],"prefix":"10.1186","volume":"14","author":[{"given":"Toshiki","family":"Maeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Babazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,8]]},"reference":[{"key":"3438_CR1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H: Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977, 50: 481-492.","journal-title":"Blood"},{"key":"3438_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-4690-2-16","volume":"2","author":"K Takatsuki","year":"2005","unstructured":"Takatsuki K: Discovery of adult T-cell leukemia. Retrovirology. 2005, 2: 16.","journal-title":"Retrovirology"},{"issue":"26","key":"3438_CR3","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","volume":"332","author":"PS Gill","year":"1995","unstructured":"Gill PS, Harrington W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S, Kornblau S, Pike MC, Levine AM: Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995, 332 (26): 1744-1748.","journal-title":"N Engl J Med"},{"issue":"3","key":"3438_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M: Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387). Br J Haematol. 1991, 79 (3): 428-437.","journal-title":"Br J Haematol"},{"issue":"3","key":"3438_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","volume":"27","author":"K Tsukasaki","year":"2009","unstructured":"Tsukasaki K, Hermine O, Bazarbachi A: Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol. 2009, 27 (3): 453-459.","journal-title":"J Clin Oncol"},{"key":"3438_CR6","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"AP Fernando","year":"2005","unstructured":"Fernando AP, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL: Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005, 24: 6058-6068.","journal-title":"Oncogene"},{"key":"3438_CR7","volume-title":"The Research for Standardization of Health Guidance to Prevent HTLV-1 Maternal-Fetal Transmission","author":"H Moriuchi","year":"2010","unstructured":"Moriuchi H: The Research for Standardization of Health Guidance to Prevent HTLV-1 Maternal-Fetal Transmission. 2010, in Japanese: Ministry of Health, Labour and Welfare science research grant report"},{"key":"3438_CR8","volume-title":"The Research for Prevention of HTLV-1 Maternal-Fetal Transmission","author":"S Saito","year":"2009","unstructured":"Saito S: The Research for Prevention of HTLV-1 Maternal-Fetal Transmission. 2009, Japanese: Ministry of Health, Labour and Welfare science research grant report"},{"key":"3438_CR9","volume-title":"The Comprehensive Survey of HTLV-1 Infection and HTLV-1 Associated Diseases","author":"K Yamaguchi","year":"2009","unstructured":"Yamaguchi K: The Comprehensive Survey of HTLV-1 Infection and HTLV-1 Associated Diseases. 2009, Japanese: Ministry of Health, Labour and Welfare science research grant report"},{"key":"3438_CR10","unstructured":"Comprehensive Strategy for HTLV-1 Infection. 2010, Ministry of Health, Labour and Welfare, http:\/\/www.mhlw.go.jp\/bunya\/kenkou\/kekkaku-kansenshou29\/taisaku.html (in Japanese, accessed Sep 05, 2013)"},{"key":"3438_CR11","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/bmt.2008.104","volume":"42","author":"A Gratwohl","year":"2008","unstructured":"Gratwohl A, Baldomero H, Frauendorfer K, Niederwieser D, Joint Accreditation Committee of the International Society for Cellular Therapy ISCT; European Group for Blood and Marrow Transplantation EMBT (JACIE): Why are there regional differences in stem cell transplantation activity? An EBMT analysis. Bone Marrow Transplant. 2008, 42: S7-S10. doi:10.1038\/bmt.2008.104","journal-title":"Bone Marrow Transplant"},{"issue":"9796","key":"3438_CR12","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(11)60828-3","volume":"378","author":"N Ikegami","year":"2011","unstructured":"Ikegami N, Yoo BK, Hashimoto H, Matsumoto M, Ogata H, Babazono A, Watanabe R, Shibuya K, Yang BM, Reich MR, Kobayashi Y: Japanese universal health coverage: evolution, achievements, and challenges. Lancet. 2011, 378 (9796): 1106-1115. doi:10.1016\/S0140-6736(11)60828-3. Epub 2011 Aug 30]","journal-title":"Lancet"},{"issue":"3","key":"3438_CR13","first-page":"25","volume":"14","author":"S Matsuda","year":"2008","unstructured":"Matsuda S, Ishikawa KB, Kuwabara K, Fujimori K, Fushimi K, Hashimoto H: Development and use of the Japanese case-mix system. Euro Health. 2008, 14 (3): 25-30.","journal-title":"Euro Health"},{"key":"3438_CR14","unstructured":"Matsuda S: Casemix as a tool for transparency of medical services. Jpn J Social Secur Policy. 2007, 6 (1)."},{"key":"3438_CR15","unstructured":"Japan Society for Hematopoietic Stem Cell Transplantation. http:\/\/www.jshct.com\/english\/ (last access May21.2014)"},{"key":"3438_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M: Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370: 1453-1457.","journal-title":"Lancet"},{"key":"3438_CR17","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajana","year":"2004","unstructured":"Sundararajana V, Hendersona T, Perrya C, Muggivana A, Quanb H, Ghali WA: New ICD-10 version of the Charlson Comorbidity Index predicted in-hospital mortality. J Clin Epidemiol. 2004, 57: 1288-1294.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"3438_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.healthpol.2007.07.015","volume":"85","author":"K Kuwabara","year":"2008","unstructured":"Kuwabara K, Imanaka Y, Matsuda S, Fushimi K, Hashimoto H, Ishikawa KB, Horiguchi H, Hayashida K, Fujimori K: Impact of age and procedure on resource use for patients with ischemic heart disease. Health Policy. 2008, 85 (2): 196-206.","journal-title":"Health Policy"},{"key":"3438_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2141.2002.03440.x","volume":"117","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Passweg J, Baldomero H, Bruno H: Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. Br J Haematol. 2002, 117: 451-468.","journal-title":"Br J Haematol"},{"key":"3438_CR20","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.3324\/haematol.11260","volume":"92","author":"A Gratwohl","year":"2007","unstructured":"Gratwohl A, Baldomero H, Schwendener A: Predictability of hematopoietic stem cell transplantation rates. Haematologica. 2007, 92: 1679-1686.","journal-title":"Haematologica"},{"key":"3438_CR21","unstructured":"Guidance for Industry - Food and Drug Administration. http:\/\/www.fda.gov\/downloads\/Drugs\/\u2026\/Guidances\/ucm071590.pdf (last access :May20.2014)"},{"issue":"12","key":"3438_CR22","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/sj.bmt.1704461","volume":"33","author":"PF Thall","year":"2004","unstructured":"Thall PF, Champlin RE, Andersson BS: Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment and center effects. Bone Marrow Transplant. 2004, 33 (12): 1191-1199.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"3438_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1056\/NEJMsb0911104","volume":"362","author":"MC Weinstein","year":"2010","unstructured":"Weinstein MC, Skinner JA: Comparative effectiveness and health care spending\u2013implications for reform. N Engl J Med. 2010, 362 (5): 460-465. doi:10.1056\/NEJMsb0911104. Epub 2010 Jan 6","journal-title":"N Engl J Med"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6963-14-337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6963-14-337\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6963-14-337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6963-14-337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T00:57:28Z","timestamp":1598144248000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/1472-6963-14-337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,8]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3438"],"URL":"https:\/\/doi.org\/10.1186\/1472-6963-14-337","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,8]]},"assertion":[{"value":"15 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"337"}}